{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T21:58:00Z","timestamp":1768427880266,"version":"3.49.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-024-03789-7","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T11:38:25Z","timestamp":1733398705000},"page":"2544-2556","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["CXCR2 expression is associated with prostate-specific membrane antigen expression in hepatocellular carcinoma: reappraisal of tumor microenvironment and angiogenesis"],"prefix":"10.1007","volume":"27","author":[{"given":"Eundong","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nusret Bekir","family":"Subasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Kmeid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chelsea","family":"Tooke-Barry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7005-6278","authenticated-orcid":false,"given":"Hwajeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,5]]},"reference":[{"issue":"7","key":"3789_CR1","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.2967\/jnumed.117.203877","volume":"59","author":"DS O\u2019Keefe","year":"2018","unstructured":"O\u2019Keefe DS, Bacich DJ, Huang SS, Heston WDW. A perspective on the evolving story of PSMA biology, PSMA-based imaging, and endoradiotherapeutic strategies. J Nucl Med. 2018;59(7):1007\u201313.","journal-title":"J Nucl Med"},{"issue":"5","key":"3789_CR2","doi-asserted-by":"publisher","first-page":"C975","DOI":"10.1152\/ajpcell.00506.2004","volume":"288","author":"AK Rajasekaran","year":"2005","unstructured":"Rajasekaran AK, Anilkumar G, Christiansen JJ. Is prostate-specific membrane antigen a multifunctional protein? Am J Physiol Cell Physiol. 2005;288(5):C975-981.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"9","key":"3789_CR3","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1158\/1078-0432.CCR-22-2875","volume":"29","author":"J Fallah","year":"2023","unstructured":"Fallah J, Agrawal S, Gittleman H, Fiero MH, Subramaniam S, John C, et al. FDA approval summary: lutetium Lu 177 vipivotide tetraxetan for patients with metastatic castration-resistant prostate cancer. Clin Cancer Res. 2023;29(9):1651\u20137.","journal-title":"Clin Cancer Res"},{"issue":"10","key":"3789_CR4","first-page":"2674","volume":"5","author":"SS Chang","year":"1999","unstructured":"Chang SS, O\u2019Keefe DS, Bacich DJ, Reuter VE, Heston WD, Gaudin PB. Prostate-specific membrane antigen is produced in tumor-associated neovasculature. Clin Cancer Res. 1999;5(10):2674\u201381.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3789_CR5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13000-020-00982-4","volume":"15","author":"W Chen","year":"2020","unstructured":"Chen W, Lee Z, Awadallah A, Zhou L, Xin W. Peritumoral\/vascular expression of PSMA as a diagnostic marker in hepatic lesions. Diagn Pathol. 2020;15(1):92.","journal-title":"Diagn Pathol"},{"issue":"41","key":"3789_CR6","doi-asserted-by":"publisher","first-page":"4149","DOI":"10.18632\/oncotarget.27024","volume":"10","author":"Y Tolkach","year":"2019","unstructured":"Tolkach Y, Goltz D, Kremer A, Ahmadzadehfar H, Bergheim D, Essler M, et al. Prostate-specific membrane antigen expression in hepatocellular carcinoma: potential use for prognosis and diagnostic imaging. Oncotarget. 2019;10(41):4149\u201360.","journal-title":"Oncotarget"},{"issue":"12","key":"3789_CR7","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1097\/PAS.0000000000001971","volume":"46","author":"M Kmeid","year":"2022","unstructured":"Kmeid M, Park YN, Chung T, Lukose G, Sullivan L, Brar R, et al. PSMA Immunohistochemistry in Hepatic Neoplasms: A Promising Diagnostic Marker With Potential Theranostic Applications. Am J Surg Pathol. 2022;46(12):1688\u201399.","journal-title":"Am J Surg Pathol"},{"issue":"48","key":"3789_CR8","doi-asserted-by":"publisher","first-page":"7664","DOI":"10.3748\/wjg.v26.i48.7664","volume":"26","author":"LX Chen","year":"2020","unstructured":"Chen LX, Zou SJ, Li D, Zhou JY, Cheng ZT, Zhao J, et al. Prostate-specific membrane antigen expression in hepatocellular carcinoma, cholangiocarcinoma, and liver cirrhosis. World J Gastroenterol. 2020;26(48):7664\u201378.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"3789_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14309\/ctg.0000000000000041","volume":"10","author":"D Jiao","year":"2019","unstructured":"Jiao D, Li Y, Yang F, Han D, Wu J, Shi S, et al. Expression of prostate-specific membrane antigen in tumor-associated vasculature predicts poor prognosis in hepatocellular carcinoma. Clin Transl Gastroenterol. 2019;10(5):1\u20137.","journal-title":"Clin Transl Gastroenterol"},{"issue":"3","key":"3789_CR10","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s00259-020-05017-0","volume":"48","author":"J Kunikowska","year":"2021","unstructured":"Kunikowska J, Cieslak B, Gierej B, Patkowski W, Kraj L, Kotulski M, et al.  [(68) Ga]Ga-prostate-specific membrane antigen PET\/CT: a novel method for imaging patients with hepatocellular carcinoma. Eur J Nucl Med Mol Imaging. 2021;48(3):883\u201392.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"3789_CR11","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1002\/hep4.1861","volume":"6","author":"SM Thompson","year":"2022","unstructured":"Thompson SM, Suman G, Torbenson MS, Chen ZE, Jondal DE, Patra A, et al. PSMA as a theranostic target in hepatocellular carcinoma: immunohistochemistry and (68) Ga-PSMA-11 PET using cyclotron-produced (68) Ga. Hepatol Commun. 2022;6(5):1172\u201385.","journal-title":"Hepatol Commun"},{"issue":"5","key":"3789_CR12","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374.","journal-title":"Cell"},{"issue":"5","key":"3789_CR13","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/nrclinonc.2011.30","volume":"8","author":"AX Zhu","year":"2011","unstructured":"Zhu AX, Duda DG, Sahani DV, Jain RK. HCC and angiogenesis: possible targets and future directions. Nat Rev Clin Oncol. 2011;8(5):292\u2013301.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"3789_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.20892\/j.issn.2095-3941.2022.0449","volume":"20","author":"C Yao","year":"2023","unstructured":"Yao C, Wu S, Kong J, Sun Y, Bai Y, Zhu R, et al. Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies. Cancer Biol Med. 2023;20(1):25\u201343.","journal-title":"Cancer Biol Med"},{"issue":"3","key":"3789_CR15","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1158\/1078-0432.CCR-18-1254","volume":"25","author":"MA Morse","year":"2019","unstructured":"Morse MA, Sun W, Kim R, He AR, Abada PB, Mynderse M, et al. The Role of Angiogenesis in Hepatocellular Carcinoma. Clin Cancer Res. 2019;25(3):912\u201320.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"3789_CR16","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/ar.20668","volume":"291","author":"ZF Yang","year":"2008","unstructured":"Yang ZF, Poon RT. Vascular changes in hepatocellular carcinoma. Anat Rec (Hoboken). 2008;291(6):721\u201334.","journal-title":"Anat Rec (Hoboken)"},{"issue":"9","key":"3789_CR17","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/S0046-8177(98)90205-2","volume":"29","author":"T Torimura","year":"1998","unstructured":"Torimura T, Sata M, Ueno T, Kin M, Tsuji R, Suzaku K, et al. Increased expression of vascular endothelial growth factor is associated with tumor progression in hepatocellular carcinoma. Hum Pathol. 1998;29(9):986\u201391.","journal-title":"Hum Pathol"},{"issue":"7","key":"3789_CR18","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.5858\/2000-124-1061-IEOVEG","volume":"124","author":"YN Park","year":"2000","unstructured":"Park YN, Kim YB, Yang KM, Park C. Increased expression of vascular endothelial growth factor and angiogenesis in the early stage of multistep hepatocarcinogenesis. Arch Pathol Lab Med. 2000;124(7):1061\u20135.","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"3789_CR19","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/S0046-8177(97)90179-9","volume":"28","author":"NH Chow","year":"1997","unstructured":"Chow NH, Hsu PI, Lin XZ, Yang HB, Chan SH, Cheng KS, et al. Expression of vascular endothelial growth factor in normal liver and hepatocellular carcinoma: an immunohistochemical study. Hum Pathol. 1997;28(6):698\u2013703.","journal-title":"Hum Pathol"},{"issue":"8","key":"3789_CR20","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1158\/1078-0432.CCR-11-2175","volume":"18","author":"JM Llovet","year":"2012","unstructured":"Llovet JM, Pe\u00f1a CE, Lathia CD, Shan M, Meinhardt G, Bruix J. Plasma biomarkers as predictors of outcome in patients with advanced hepatocellular carcinoma. Clin Cancer Res. 2012;18(8):2290\u2013300.","journal-title":"Clin Cancer Res"},{"issue":"21","key":"3789_CR21","doi-asserted-by":"publisher","first-page":"10307","DOI":"10.18632\/oncotarget.2537","volume":"5","author":"T Wei","year":"2014","unstructured":"Wei T, Zhang LN, Lv Y, Ma XY, Zhi L, Liu C, et al. Overexpression of platelet-derived growth factor receptor alpha promotes tumor progression and indicates poor prognosis in hepatocellular carcinoma. Oncotarget. 2014;5(21):10307\u201317.","journal-title":"Oncotarget"},{"key":"3789_CR22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3389\/fonc.2014.00069","volume":"4","author":"C Stockmann","year":"2014","unstructured":"Stockmann C, Schadendorf D, Klose R, Helfrich I. The impact of the immune system on tumor: angiogenesis and vascular remodeling. Front Oncol. 2014;4:69.","journal-title":"Front Oncol"},{"key":"3789_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2020.104119","volume":"353","author":"LQ Fu","year":"2020","unstructured":"Fu LQ, Du WL, Cai MH, Yao JY, Zhao YY, Mou XZ. The roles of tumor-associated macrophages in tumor angiogenesis and metastasis. Cell Immunol. 2020;353: 104119.","journal-title":"Cell Immunol"},{"issue":"2","key":"3789_CR24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1158\/2326-6066.CIR-15-0313","volume":"4","author":"W Liang","year":"2016","unstructured":"Liang W, Ferrara N. The complex role of neutrophils in tumor angiogenesis and metastasis. Cancer Immunol Res. 2016;4(2):83\u201391.","journal-title":"Cancer Immunol Res"},{"issue":"9","key":"3789_CR25","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-11-3687","volume":"72","author":"A Facciabene","year":"2012","unstructured":"Facciabene A, Motz GT, Coukos G. T-regulatory cells: key players in tumor immune escape and angiogenesis. Cancer Res. 2012;72(9):2162\u201371.","journal-title":"Cancer Res"},{"issue":"7","key":"3789_CR26","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1053\/j.gastro.2016.02.040","volume":"150","author":"SL Zhou","year":"2016","unstructured":"Zhou SL, Zhou ZJ, Hu ZQ, Huang XW, Wang Z, Chen EB, et al. Tumor-associated neutrophils recruit macrophages and t-regulatory cells to promote progression of hepatocellular carcinoma and resistance to sorafenib. Gastroenterology. 2016;150(7):1646-1658.e1617.","journal-title":"Gastroenterology"},{"issue":"6","key":"3789_CR27","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.3892\/or.2014.3138","volume":"31","author":"N Fujita","year":"2014","unstructured":"Fujita N, Nishie A, Aishima S, Kubo Y, Asayama Y, Ishigami K, et al. Role of tumor-associated macrophages in the angiogenesis of well-differentiated hepatocellular carcinoma: pathological-radiological correlation. Oncol Rep. 2014;31(6):2499\u2013505.","journal-title":"Oncol Rep"},{"key":"3789_CR28","doi-asserted-by":"publisher","first-page":"106689692412267","DOI":"10.1177\/10668969241226705","volume":"32","author":"RX Li","year":"2024","unstructured":"Li RX, Hao Y, Ettel M. Expression of PSMA in tumor-associated vasculature predicts poorer survival in patients with hepatocellular carcinoma and is likely associated with PD-L1. Int J Surg Pathol. 2024;32:10668969241226704.","journal-title":"Int J Surg Pathol"},{"issue":"1","key":"3789_CR29","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.molmed.2023.09.003","volume":"30","author":"G Lazennec","year":"2024","unstructured":"Lazennec G, Rajarathnam K, Richmond A. CXCR2 chemokine receptor - a master regulator in cancer and physiology. Trends Mol Med. 2024;30(1):37\u201355.","journal-title":"Trends Mol Med"},{"issue":"9","key":"3789_CR30","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1172\/JCI61067","volume":"122","author":"T Jamieson","year":"2012","unstructured":"Jamieson T, Clarke M, Steele CW, Samuel MS, Neumann J, Jung A, et al. Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis. J Clin Invest. 2012;122(9):3127\u201344.","journal-title":"J Clin Invest"},{"issue":"11","key":"3789_CR31","first-page":"2254","volume":"7","author":"X Song","year":"2015","unstructured":"Song X, Wang Z, Jin Y, Wang Y, Duan W. Loss of miR-532-5p in vitro promotes cell proliferation and metastasis by influencing CXCL2 expression in HCC. Am J Transl Res. 2015;7(11):2254\u201361.","journal-title":"Am J Transl Res"},{"issue":"5","key":"3789_CR32","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.3892\/or.2013.2674","volume":"30","author":"T Nomura","year":"2013","unstructured":"Nomura T, Morishita A, Jian G, Mimura S, Kato K, Nomura K, et al. Expression of angiogenic factors in hepatocarcinogenesis: Identification by antibody arrays. Oncol Rep. 2013;30(5):2476\u201380.","journal-title":"Oncol Rep"},{"key":"3789_CR33","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13046-015-0247-1","volume":"34","author":"L Li","year":"2015","unstructured":"Li L, Xu L, Yan J, Zhen ZJ, Ji Y, Liu CQ, et al. CXCR2-CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma. J Exp Clin Cancer Res. 2015;34:129.","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"3789_CR34","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.jhep.2010.08.041","volume":"54","author":"DM Kuang","year":"2011","unstructured":"Kuang DM, Zhao Q, Wu Y, Peng C, Wang J, Xu Z, et al. Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma. J Hepatol. 2011;54(5):948\u201355.","journal-title":"J Hepatol"},{"issue":"1","key":"3789_CR35","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):6.","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"3789_CR36","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/his.13975","volume":"76","author":"ID Nagtegaal","year":"2020","unstructured":"Nagtegaal ID, Odze RD, Klimstra D, Paradis V, Rugge M, Schirmacher P, et al. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2020;76(2):182\u20138.","journal-title":"Histopathology"},{"issue":"6","key":"3789_CR37","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.ajpath.2022.02.004","volume":"192","author":"L Pham","year":"2022","unstructured":"Pham L, Kyritsi K, Zhou T, Ceci L, Baiocchi L, Kennedy L, et al. The Functional Roles of Immune Cells in Primary Liver Cancer. Am J Pathol. 2022;192(6):826\u201336.","journal-title":"Am J Pathol"},{"key":"3789_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.646387","volume":"11","author":"A Holzgreve","year":"2021","unstructured":"Holzgreve A, Biczok A, Ruf VC, Liesche-Starnecker F, Steiger K, Kirchner MA, et al. PSMA expression in glioblastoma as a basis for theranostic approaches: a retrospective, correlational panel study including immunohistochemistry, clinical parameters and PET imaging. Front Oncol. 2021;11: 646387.","journal-title":"Front Oncol"},{"issue":"12","key":"3789_CR39","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1093\/jnen\/nlac089","volume":"81","author":"T Tubre","year":"2022","unstructured":"Tubre T, Hacking S, Alexander A, Brickman A, Delalle I, Elinzano H, et al. Prostate-specific membrane antigen expression in meningioma: a promising theranostic target. J Neuropathol Exp Neurol. 2022;81(12):1008\u201317.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"7","key":"3789_CR40","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","volume":"158","author":"TG Cotter","year":"2020","unstructured":"Cotter TG, Rinella M. Nonalcoholic Fatty Liver Disease 2020: The State of the Disease. Gastroenterology. 2020;158(7):1851\u201364.","journal-title":"Gastroenterology"},{"key":"3789_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.114990","volume":"199","author":"W Xu","year":"2022","unstructured":"Xu W, Cheng Y, Guo Y, Yao W, Qian H. Targeting tumor associated macrophages in hepatocellular carcinoma. Biochem Pharmacol. 2022;199: 114990.","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"3789_CR42","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jss.2009.07.014","volume":"166","author":"Z Liu","year":"2011","unstructured":"Liu Z, Yang L, Xu J, Zhang X, Wang B. Enhanced expression and clinical significance of chemokine receptor CXCR2 in hepatocellular carcinoma. J Surg Res. 2011;166(2):241\u20136.","journal-title":"J Surg Res"},{"issue":"5","key":"3789_CR43","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.4049\/jimmunol.172.5.2853","volume":"172","author":"MP Keane","year":"2004","unstructured":"Keane MP, Belperio JA, Xue YY, Burdick MD, Strieter RM. Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer. J Immunol. 2004;172(5):2853\u201360.","journal-title":"J Immunol"},{"issue":"3","key":"3789_CR44","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/hep.28368","volume":"63","author":"F Piscaglia","year":"2016","unstructured":"Piscaglia F, Svegliati-Baroni G, Barchetti A, Pecorelli A, Marinelli S, Tiribelli C, et al. Group H-NIS: Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: a multicenter prospective study. Hepatology. 2016;63(3):827\u201338.","journal-title":"Hepatology"},{"issue":"7854","key":"3789_CR45","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41586-021-03362-0","volume":"592","author":"D Pfister","year":"2021","unstructured":"Pfister D, Nunez NG, Pinyol R, Govaere O, Pinter M, Szydlowska M, et al. NASH limits anti-tumour surveillance in immunotherapy-treated HCC. Nature. 2021;592(7854):450\u20136.","journal-title":"Nature"},{"issue":"10","key":"3789_CR46","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1136\/gutjnl-2021-326259","volume":"71","author":"J Leslie","year":"2022","unstructured":"Leslie J, Mackey JBG, Jamieson T, Ramon-Gil E, Drake TM, Fercoq F, et al. CXCR2 inhibition enables NASH-HCC immunotherapy. Gut. 2022;71(10):2093\u2013106.","journal-title":"Gut"},{"issue":"4_suppl","key":"3789_CR47","doi-asserted-by":"publisher","first-page":"TPS631","DOI":"10.1200\/JCO.2023.41.4_suppl.TPS631","volume":"41","author":"TRJ Evans","year":"2023","unstructured":"Evans TRJ, Basu B, Hubner R, Ma YT, Meyer T, Palmer DH, et al. A phase I\/II study of the CXCR2 inhibitor, AZD5069, in combination with durvalumab, in patients (pts) with advanced hepatocellular carcinoma (HCC). J Clin Oncol. 2023;41(4_suppl):TPS631.","journal-title":"J Clin Oncol"},{"issue":"5","key":"3789_CR48","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.amjsurg.2017.08.003","volume":"214","author":"B Hurt","year":"2017","unstructured":"Hurt B, Schulick R, Edil B, El Kasmi KC, Barnett C Jr. Cancer-promoting mechanisms of tumor-associated neutrophils. Am J Surg. 2017;214(5):938\u201344.","journal-title":"Am J Surg"},{"issue":"7","key":"3789_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041285","volume":"7","author":"CL Grant","year":"2012","unstructured":"Grant CL, Caromile LA, Ho V, Durrani K, Rahman MM, Claffey KP, et al. Prostate specific membrane antigen (PSMA) regulates angiogenesis independently of VEGF during ocular neovascularization. PLoS ONE. 2012;7(7): e41285.","journal-title":"PLoS ONE"},{"key":"3789_CR50","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/978-3-030-44518-8_4","volume-title":"Tumor microenvironment: state of the science","author":"D Dandachi","year":"2020","unstructured":"Dandachi D, Mor\u00f3n F. Effects of HIV on the tumor microenvironment. In: Birbrair A, editor. Tumor microenvironment: state of the science. Cham: Springer International Publishing; 2020. p. 45\u201354."},{"issue":"5","key":"3789_CR51","doi-asserted-by":"publisher","first-page":"473","DOI":"10.2217\/bmm.15.13","volume":"9","author":"JG Taylor","year":"2015","unstructured":"Taylor JG, Liapis K, Gribben JG. The role of the tumor microenvironment in HIV-associated lymphomas. Biomark Med. 2015;9(5):473\u201382.","journal-title":"Biomark Med"},{"issue":"10","key":"3789_CR52","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1182\/blood-2011-06-364083","volume":"119","author":"C Giagulli","year":"2012","unstructured":"Giagulli C, Magiera AK, Bugatti A, Caccuri F, Marsico S, Rusnati M, et al. HIV-1 matrix protein p17 binds to the IL-8 receptor CXCR1 and shows IL-8-like chemokine activity on monocytes through Rho\/ROCK activation. Blood. 2012;119(10):2274\u201383.","journal-title":"Blood"},{"issue":"36","key":"3789_CR53","doi-asserted-by":"publisher","first-page":"14580","DOI":"10.1073\/pnas.1206605109","volume":"109","author":"F Caccuri","year":"2012","unstructured":"Caccuri F, Giagulli C, Bugatti A, Benetti A, Alessandri G, Ribatti D, et al. HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2. Proc Natl Acad Sci U S A. 2012;109(36):14580\u20135.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-024-03789-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-024-03789-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-024-03789-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T15:03:07Z","timestamp":1747407787000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-024-03789-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,5]]},"references-count":53,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["3789"],"URL":"https:\/\/doi.org\/10.1007\/s12094-024-03789-7","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,5]]},"assertion":[{"value":"14 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Approved by institutional review board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent"}}]}}